Target intelligence / Profile preview

Intestinal epithelial barrier proteins

Molecular classification
Cell adhesion molecule, Structural protein, Scaffolding protein, Tight junction protein
01

Overview

The intestinal epithelial barrier is a critical physiological system composed of a single layer of epithelial cells and their associated junctional complexes, including tight junctions, adherens junctions, and desmosomes (PMID: 23307037). Its primary function is to maintain a selective barrier that allows for the absorption of nutrients and water while preventing the translocation of luminal pathogens, toxins, and antigens into the systemic circulation (PMID: 28123248). Key proteins involved in this structure include claudins, occludin, and zonula occludens-1 (ZO-1), which regulate paracellular permeability. Impairment of these proteins leads to increased intestinal permeability, a condition associated with inflammatory bowel disease, celiac disease, and various metabolic disorders (PMID: 33072622). Therapeutic interventions aim to stabilize these protein-protein interactions or inhibit regulatory pathways, such as the zonulin pathway, to restore barrier integrity and reduce systemic inflammation (PMID: 25567115).

Other names
Intestinal mucosal barrierGut barrierTight junction complexIntestinal permeability barrier
02

Mechanism of action

Pharmacological agents target the intestinal barrier by inhibiting zonulin-mediated tight junction disassembly, activating chloride channels to promote mucosal repair, or reducing pro-inflammatory cytokines that degrade junctional proteins (PMID: 25567115, 28123248).

03

Biological functions

Barrier functionSelective permeabilityCell-cell adhesionImmune homeostasisNutrient absorption
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseIrritable bowel syndromeSepsisType 1 diabetesNon-alcoholic fatty liver disease
05

Safety considerations

Risk of systemic toxicity from increased permeabilityPotential for malabsorption of essential nutrientsOff-target effects on other epithelial barriersImmunogenicity of therapeutic peptides
06

Interacting drugs

Larazotide acetate

5 more in the full profile.

07

Biomarkers

ZonulinLactulose/Mannitol ratioIntestinal fatty acid-binding protein (I-FABP)Fecal calprotectinCitrulline

Beyond the preview

Go deeper on Intestinal epithelial barrier proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial barrier proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call